Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC
Clinical trial NCT05898373 · UNKNOWN
Trial details
- NCT number
- NCT05898373
- Sponsor
- Peking Union Medical College
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2025-06-06
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.